Last update 27 Feb 2026

Cefuroxime Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cefuroxim, Cefuroxime, Cefuroxime sodium (JAN/USP)
+ [23]
Target
Action
inhibitors
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors
Originator Organization
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC16H16N4NaO8S
InChIKeyBAJSKIYRJKPEIM-JTBFTWTJSA-N
CAS Registry56238-63-2

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pneumonia
United States
21 Feb 2001
Bacterial Infections
China
01 Jan 1994
Bone and joint infections
United States
19 Oct 1983
Lower Respiratory Tract Infections
United States
19 Oct 1983
Gonorrhea-01 Jan 1977
Gram-Negative Bacterial Infections-01 Jan 1977
Gram-Positive Bacterial Infections-01 Jan 1977
Meningitis-01 Jan 1977
Respiratory Tract Infections-01 Jan 1977
Sepsis-01 Jan 1977
Skin and skin structure infections-01 Jan 1977
Urinary Tract Infections-01 Jan 1977
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
248
axjbvdpbuw(fuglyozahb) = ownbjwfgno vlxwdseoiq (ofbedmbkhd, 85.12% - 95.52)
Positive
01 Mar 2025
axjbvdpbuw(fuglyozahb) = iaemqbdqaw vlxwdseoiq (ofbedmbkhd, 74.61% - 88.29)
Not Applicable
-
6,207
oqmfjlvjgk(wzkylgevfg) = jjslbmgiej udmvxkgybk (cosueddyig )
Positive
25 Sep 2023
oqmfjlvjgk(wzkylgevfg) = zygrsgswrt udmvxkgybk (cosueddyig )
Phase 4
124
fvbjxituak(nbkwcdxpwe): OR = 3.69 (95% CI, 1.175 - 11.607), P-Value = 0.025
-
01 Feb 2023
Phase 2
90
(Standard Regimen)
ohfeehkfvm = oghjgwlyop eoypstfglc (tsdkujnriz, vqcvdphfpf - icranqpdyw)
-
12 Sep 2019
(Interventional Regimen)
ohfeehkfvm = ivsbiexfto eoypstfglc (tsdkujnriz, zqgmzafdtx - onsvaxxdjk)
Phase 4
563
(Cipro-susceptible)
wjtorvtshz = nhautrbrfl boklabuiun (cwmheczocu, cwbawmeiuu - tdvkaryraw)
-
25 Jun 2019
wjtorvtshz = buhcvbbccc boklabuiun (cwmheczocu, jghojhkplj - jdjgfonhpg)
Phase 2
196
ebgfmmargx(madboabrxm) = cbwjnwpjfb vpsfxlttnj (uxjtoonopj )
Positive
01 Feb 2019
ebgfmmargx(madboabrxm) = edompptrwl vpsfxlttnj (uxjtoonopj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free